Literature DB >> 31131983

Updated hypertension prevalence, awareness, and control rates based on the 2017ACC/AHA high blood pressure guideline.

Yaqing Zhou1, Limei Jia2, Baojin Lu2, Guoqiang Gu1, Haijuan Hu1, Ziyuan Zhang1, Long Bai1, Wei Cui1.   

Abstract

In 2017, the American College of Cardiology/American Heart Association (ACC/AHA) updated the Guideline of Prevention, Detection, Evaluation and Management and Management of High Blood Pressure (HBP) in Adults. The purpose of the current study was to evaluate the potential impact of the 2017ACC/AHA HBP guideline on hypertension prevalence, awareness, and control rates. The data were collected from Physical Examination Center of the Second Hospital of Hebei Medical University from January 2012 to December 2017 (N = 66 977), including demographic information and risk factors of hypertension. The hypertension prevalence, awareness, and control rates of people were evaluated according to the new guideline. Additionally, the factors related to hypertension prevalence were also assessed. According to previous HBP guideline, hypertension prevalence, awareness, and control rate were 30.54%, 44.33%, and 13.04%, respectively. However, when the 2017 ACC/AHA HBP guideline was introduced, the population with hypertension increased from 20 453 to 34 460, the hypertension prevalence rate increased from 30.54% to 51.45%, the awareness rate decreased from 44.33% to 26.31%, and the control rate declined from 13.04% to 2.72%. The most newly diagnosed hypertension patients were from the low-risk population with young age and without the above histories. The 2017ACC/AHA HBP guideline indicated that high hypertension prevalence rate still existed with a substantial increase, while the awareness and control rates were relatively lowered. ©2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  awareness rate; control rate; high blood pressure guideline; hypertension; prevalence rate

Mesh:

Year:  2019        PMID: 31131983      PMCID: PMC8030613          DOI: 10.1111/jch.13564

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  28 in total

1.  The 2017 American College of Cardiology/American Heart Association hypertension guideline and opportunities for community pharmacists.

Authors:  Dave L Dixon; Teresa M Salgado; Lauren M Caldas; Benjamin W Van Tassell; Evan M Sisson
Journal:  J Am Pharm Assoc (2003)       Date:  2018-05-24

2.  Baseline Blood Pressure, the 2017 ACC/AHA High Blood Pressure Guidelines, and Long-Term Cardiovascular Risk in SPRINT.

Authors:  Muthiah Vaduganathan; Manan Pareek; Arman Qamar; Ambarish Pandey; Michael H Olsen; Deepak L Bhatt
Journal:  Am J Med       Date:  2018-02-05       Impact factor: 4.965

Review 3.  The primary health-care system in China.

Authors:  Xi Li; Jiapeng Lu; Shuang Hu; K K Cheng; Jan De Maeseneer; Qingyue Meng; Elias Mossialos; Dong Roman Xu; Winnie Yip; Hongzhao Zhang; Harlan M Krumholz; Lixin Jiang; Shengshou Hu
Journal:  Lancet       Date:  2017-12-08       Impact factor: 79.321

Review 4.  Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.

Authors:  Dena Ettehad; Connor A Emdin; Amit Kiran; Simon G Anderson; Thomas Callender; Jonathan Emberson; John Chalmers; Anthony Rodgers; Kazem Rahimi
Journal:  Lancet       Date:  2015-12-24       Impact factor: 79.321

5.  Evaluating community health centers in the City of Dalian, China: how satisfied are patients with the medical services provided and their health professionals?

Authors:  Hassan H Dib; Ping Sun; Zhu Minmin; Shenhai Wei; Li Li
Journal:  Health Place       Date:  2009-12-16       Impact factor: 4.078

6.  Status of Hypertension in China: Results From the China Hypertension Survey, 2012-2015.

Authors:  Zengwu Wang; Zuo Chen; Linfeng Zhang; Xin Wang; Guang Hao; Zugui Zhang; Lan Shao; Ye Tian; Ying Dong; Congyi Zheng; Jiali Wang; Manlu Zhu; William S Weintraub; Runlin Gao
Journal:  Circulation       Date:  2018-02-15       Impact factor: 29.690

7.  Geographical variations in hypertension prevalence, awareness, treatment and control in China: findings from a nationwide and provincially representative survey.

Authors:  Yichong Li; Limin Wang; Xiaoqi Feng; Mei Zhang; Zhengjing Huang; Qian Deng; Maigeng Zhou; Thomas Astell-Burt; Linhong Wang
Journal:  J Hypertens       Date:  2018-01       Impact factor: 4.844

8.  Prevalence and determinants of hypertension in Abia State Nigeria: results from the Abia State Non-Communicable Diseases and Cardiovascular Risk Factors Survey.

Authors:  Okechukwu S Ogah; Okechukwu O Madukwe; Innocent I Chukwuonye; Ugochukwu U Onyeonoro; Andrew U Ukegbu; Moses O Akhimien; Basden J C Onwubere; Ikechi G Okpechi
Journal:  Ethn Dis       Date:  2013       Impact factor: 1.847

9.  Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project).

Authors:  Jiapeng Lu; Yuan Lu; Xiaochen Wang; Xinyue Li; George C Linderman; Chaoqun Wu; Xiuyuan Cheng; Lin Mu; Haibo Zhang; Jiamin Liu; Meng Su; Hongyu Zhao; Erica S Spatz; John A Spertus; Frederick A Masoudi; Harlan M Krumholz; Lixin Jiang
Journal:  Lancet       Date:  2017-11-05       Impact factor: 79.321

10.  Association between Body Mass Index and All-Cause Mortality in Hypertensive Adults: Results from the China Stroke Primary Prevention Trial (CSPPT).

Authors:  Wei Yang; Jian-Ping Li; Yan Zhang; Fang-Fang Fan; Xi-Ping Xu; Bin-Yan Wang; Xin Xu; Xian-Hui Qin; Hou-Xun Xing; Gen-Fu Tang; Zi-Yi Zhou; Dong-Feng Gu; Dong Zhao; Yong Huo
Journal:  Nutrients       Date:  2016-06-22       Impact factor: 5.717

View more
  5 in total

1.  The Translation, Reliability and Validity of the Chinese Version of the Hill-Bone Compliance to High Blood Pressure Therapy Scale in Adults with Hypertension.

Authors:  Jingjing Pan; Bin Hu; Lian Wu; Huichuan Wang; Tao Lei; Zhiyu Liu
Journal:  Patient Prefer Adherence       Date:  2020-10-09       Impact factor: 2.711

2.  Updated hypertension prevalence, awareness, and control rates based on the 2017ACC/AHA high blood pressure guideline.

Authors:  Yaqing Zhou; Limei Jia; Baojin Lu; Guoqiang Gu; Haijuan Hu; Ziyuan Zhang; Long Bai; Wei Cui
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-05-27       Impact factor: 3.738

3.  Association between Periodontitis and High Blood Pressure: Results from the Study of Periodontal Health in Almada-Seixal (SoPHiAS).

Authors:  Vanessa Machado; Eva Muñoz Aguilera; João Botelho; Syed Basit Hussain; Yago Leira; Luís Proença; Francesco D'Aiuto; José João Mendes
Journal:  J Clin Med       Date:  2020-05-23       Impact factor: 4.241

4.  Hypertension Control and Guideline-Recommended Target Blood Pressure Goal Achievement at an Early Stage of Hypertension in the UAE.

Authors:  Akshaya Srikanth Bhagavathula; Syed Mahboob Shah; Abubaker Suliman; Abderrahim Oulhaj; Elhadi Husein Aburawi
Journal:  J Clin Med       Date:  2021-12-23       Impact factor: 4.241

5.  Simple renal cyst as an independent risk factor for hypertension.

Authors:  Yaqing Zhou; Limei Jia; Baojin Lu; Long Bai; Wei Cui
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-06-08       Impact factor: 2.885

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.